Von Willebrand Factor A Domain Containing 5A (VWA5A) Peptide
VWA5A
Reactivité: Humain, Souris, Singe, Rat
Hôte: Synthetic
BP
-
- Antigène Tous les produits VWA5A
- VWA5A (Von Willebrand Factor A Domain Containing 5A (VWA5A))
- Origine
- Humain, Souris, Singe, Rat
-
Source
- Synthetic
- Application
- Blocking Peptide (BP)
- Attributs du produit
- The peptide is used to block Anti-VWA5A Antibody reactivity.
-
-
- Indications d'application
- Blocking Peptide to the diluted primary antibody in a molar ratio of 10:1 (peptide to antibody) and incubate the mixture at 4 °C for overnight or at room temperature for 2 hours.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Stock
- -20 °C
- Stockage commentaire
- Shipped at 4°C. Store at -20°C for one year.
- Date de péremption
- 12 months
-
- Antigène
- VWA5A (Von Willebrand Factor A Domain Containing 5A (VWA5A))
- Synonymes
- VWA5A Peptide, LOH11CR2A Peptide, MGC68953 Peptide, loh11cr2a Peptide, BCSC-1 Peptide, BCSC1 Peptide, 5830475I06Rik Peptide, AW552491 Peptide, E130119J22 Peptide, Loh11cr2a Peptide, masa-1 Peptide, loss of heterozygosity, 11, chromosomal region 2, gene A Peptide, von Willebrand factor A domain containing 5A Peptide, von Willebrand factor A domain containing 5A S homeolog Peptide, LOH11CR2A Peptide, VWA5A Peptide, vwa5a.S Peptide, vwa5a Peptide, Vwa5a Peptide
- Sujet
- BCSC1, LOH11CR2A, von Willebrand factor A domain-containing protein 5A, Breast cancer suppressor candidate 1, BCSC-1, Loss of heterozygosity 11 chromosomal region 2 gene A protein
- ID gène
- 4013, 67776
- UniProt
- O00534, Q99KC8
-
Vous êtes ici:
